More Clinical Trials Should Combine Radiation Therapy with Promising New Cancer Drugs

The American Society for Radiation Oncology (ASTRO) today issued the following statement in support of findings from an ASTRO-commissioned task force to review opportunities to improve outcomes for cancer patients by expanding the number of clinical...
10-May-2018 3:45 PM EDT Add to Favorites

Updated ASTRO Guideline for Palliative Lung Radiation Now Recommends Concurrent Chemotherapy for Some Stage III Patients

The American Society for Radiation Oncology (ASTRO) today issued an update to its clinical guideline for the use of palliative-intent radiation therapy for patients with incurable non-small cell lung cancer (NSCLC). Reflecting new evidence from...
4-Apr-2018 8:30 AM EDT Add to Favorites

ASTRO Issues Clinical Guideline for Whole Breast Radiation Therapy

The American Society for Radiation Oncology (ASTRO) today issued a new clinical guideline for the use of whole breast radiation therapy for breast cancer that expands the population of patients recommended to receive accelerated treatment known as...
8-Mar-2018 5:00 PM EST Add to Favorites

Phase II Trial Demonstrates Activity of Durvalumab in Patients with Recurrent or Metastatic Head and Neck Cancer

Analysis of the phase II CONDOR trial indicates that the immune checkpoint inhibitor durvalumab is tolerable among heavily pre-treated patients with recurrent or metastatic head and neck cancer and has the potential to slow growth in tumors with low...
13-Feb-2018 7:05 AM EST Add to Favorites

Nivolumab Immunotherapy Safe and Feasible During Chemoradiation for Advanced Head and Neck Cancer

Analysis of a clinical trial, RTOG Foundation 3504, finds that nivolumab immunotherapy can be administered safely in conjunction with radiation therapy and chemotherapy for patients with newly diagnosed local-regionally advanced head and neck...
13-Feb-2018 7:05 AM EST Add to Favorites

Lower-Dose Radiation Therapy Effective and Safe for HPV-Related Head and Neck Cancer After Induction Chemotherapy, Trial Finds

Results of the phase II OPTIMA clinical trial indicate that patients with head and neck cancers associated with the human papillomavirus (HPV), including those with advanced nodal disease, can receive substantially lower radiation doses safely and...
13-Feb-2018 8:05 AM EST Add to Favorites

Cabozantinib Shows Significant Activity in the First Line for Differentiated Thyroid Cancer

Results of a new phase II clinical trial indicate that cabozantinib offers an active therapy option for patients with differentiated thyroid cancer (DTC) that has progressed following surgery and treatment with radioactive iodine (RAI). Thirty-four...
13-Feb-2018 7:05 AM EST Add to Favorites

ASTRO Applauds Congressional Leaders for Extending the Radiation Oncology Payment Freeze

The American Society for Radiation Oncology (ASTRO) today applauded congressional leaders for the passage of legislation to freeze payment rates for key radiation oncology services delivered in freestanding clinics.
9-Feb-2018 7:55 AM EST Add to Favorites

see all news